Euro-Med Laboratories Philippines (PHS:EURO) Dividends Paid

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
80 GF Score
Price ₱1.23
GF Value ₱1.07
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Dividends Paid?

Dividends Paid only applicable to companies reporting Cash Flow from Operations in direct method.

PHS:EURO
80GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Dividends Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.23 is trading 15% above its estimated GF Value™ of ₱1.07. GuruFocus considers Euro-Med Laboratories Philippines to be Modestly Overvalued.

Key valuation signals for PHS:EURO:

  • Dividends Paid:
  • GF Value™: ₱1.07 vs. price of ₱1.23 (15% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc. is a Philippine pharmaceutical manufacturer specializing in sterile liquid products. Its core business is the production of large- and small-volume parenterals, including intravenous fluids supplied in glass bottles and plastic containers, as well as sterile water for injection. The company also manufactures hemodialysis concentrates and related dialysis solutions, ophthalmic preparations, inhalation and irrigation solutions, and disinfectants. Its products are sold primarily to hospitals, dialysis centers, clinics, and healthcare institutions across the Philippines, with distribution through pharmaceutical and medical supply channels. Manufacturing is conducted at its facilities in the Philippines, and the company serves the domestic healthcare market, where it is a significant local supplier of intravenous and renal care solutions. Revenue is generated mainly from the sale of these manufactured pharmaceutical and medical solutions, supported by contract manufacturing and institutional supply arrangements with healthcare providers.
80GF Score

Get the complete analysis for PHS:EURO

Dividends Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.23
Price
₱1.07
GF Value